Drug Trial Radar · NCT04983043
Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
228
Actual
Start
Jul 13, 2021
Primary completion
Nov 27, 2024
Study completion Nov 27, 2024
Sponsor
- Lead sponsor
- Tasly Pharmaceutical Group Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Jul 30, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy and safety and the best effective dose of QiShen YiQi Dripping Pills in the treatment of chronic heart failure with decreased ejection fraction of CHD (Qi deficiency and blood stasis syndrome).
Conditions
- Chronic Heart Failure With Reduced Ejection Fraction
Interventions
Low dose QiShen YiQi Dripping Pills 3 bagsDrug
Low dose QiShen YiQi Dripping Pills contain QiShen YiQi Dripping Pills 2 bags(0.52g dripping pills per bag) and QiShen YiQi Dripping Pills placebo 1 bag(0.52g dripping pills placebo per bag),take orally after meals, 3 times a day for 12weeks
High dose QiShen YiQi Dripping Pills 3 bagsDrug
High dose QiShen YiQi Dripping Pills contain QiShen YiQi Dripping Pills 3 bags(0.52g dripping pills per bag),take orally after meals, 3 times a day for 12weeks
QiShen YiQi Dripping Pills placebo 3 bagsDrug
QiShen YiQi Dripping Pills placebo contain QiShen YiQi Dripping Pills placebo 3 bags(0.52g dripping pills placebo per bag),take orally after meals, 3 times a day for 12weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- 6-Minutes-Walking-Test (6MWT) in week 12Time frame: Baseline to weeks 12
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Hefei First People's Hospital
Hefei, Anhui, China
The First Hospital of ANHUI University of Science & Technology
Huainan, Anhui, China
Suzhou Municipal Hospital
Suzhou, Anhui, China
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China
Xiamen Hospital of Traditional Chinese Medicine
Xiamen, Fujian, China
Dongguan TCM Hospital
Dongguan, Guangdong, China
Nanfang Hospital,Southern Medical University
Guangzhou, Guangdong, China
The Affiliated TCM Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, China
Zhong Shan Hospital of Chinese Medicine
Zhongshan, Guangdong, China
Ruikang Hospital Affiliated to Guangxi University of Traditional Chinese Medicine
Nanning, Guangxi, China
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Harbin, Heilongjiang, China
Luoyang Third People's Hospital
Luoyang, Henan, China
The First Affiliated Hospital of Nanyang Medical College
Nanyang, Henan, China
Pepole's Hospital of Xinzheng
Zhengzhou, Henan, China
Hunan University of Chinese Medicine
Changsha, Hunan, China
The First Affiliated Hospital of University of South China
Hengyang, Hunan, China
Nanjing Hospital of Traditional Chinese Medicine
Nanjing, Jiangsu, China
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Shenyang, Liaoning, China
Xi'an Daxing Hospital
Xi'an, Shaanxi, China
The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Chengdu, Sichuan, China
The Second Affiliated Hospital of Tianjin University of traditional Chinese Medicine
Tianjin, Tianjin Municipality, China
Hospital of Traditional Chinese Medicine of Xinjiang Uygur Autonomous Region
Ürümqi, Xinjiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.